Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems

Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems

Show other versions (1)

Bibliographic Details
Main Authors:	Hugle Boris, Benseler Susanne M
Format:	Article
Language:	English
Published:	BMC 2011-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems
by: Hugle Boris, et al.
Published: (2013-01-01)

Abatacept in difficult-to-treat juvenile idiopathic arthritis
by: Jasmin B Kuemmerle-Deschner, et al.
Published: (2009-02-01)

Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis
by: Luiza R. Grazziotin, et al.
Published: (2022-07-01)

Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
by: Lea Höfel, et al.
Published: (2018-02-01)

Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication
by: Boris Hügle, et al.
Published: (2021-11-01)

ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-12-01)

Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
by: Murakami M, et al.
Published: (2012-07-01)

α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
by: Ludwig Zeller, et al.
Published: (2022-08-01)

Psychological health in juvenile idiopathic arthritis.
by: Luqmani, R, et al.
Published: (1999)

Current Treatments for Juvenile Idiopathic Arthritis
by: Alberto eMartini, et al.
Published: (2011-10-01)

Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.
by: Swaantje Barth, et al.
Published: (2016-01-01)

Adolescent and caregiver preferences for juvenile idiopathic arthritis treatment: a discrete-choice experiment
by: Flora McErlane, et al.
Published: (2023-10-01)

Education and employment in patients with juvenile idiopathic arthritis – a standardized comparison to the German general population
by: Jenny Schlichtiger, et al.
Published: (2017-05-01)

MOTION OR REST: WHAT IS MORE PREFERABLE FOR PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS?
by: T. A. Shelepina
Published: (2016-12-01)

Juvenile Idiopathic Arthritis
by: Kenan Barut, et al.
Published: (2017-04-01)

Juvenile Idiopathic Arthritis
by: Aleksandra Strońska, et al.
Published: (2021-08-01)

Juvenile idiopathic arthritis
by: Krupa H Bhatt, et al.
Published: (2014-01-01)

Systemic Onset Juvenile Idiopathic Arthritis
by: Kolesnichenko A.A., et al.
Published: (2023-08-01)

Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care
by: Claire E.H. Barber, et al.
Published: (2019-08-01)

Juvenile idiopathic arthritis – classification and methods of treatment
by: Weronika Pawłocik, et al.
Published: (2023-04-01)

Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis
by: İlknur Tuğal-Tutkun
Published: (2016-04-01)

EXPERIENCE WITH ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: Margarita Fedorovna Dubko, et al.
Published: (2012-10-01)

Intraveous gammaglobulin for the treatment of juvenil idiopathic arthritis
by: Lòpez Ortíz Daniela Jazmin, et al.
Published: (2014-07-01)

The Effect of Physiotherapy in the Treatment of Juvenile Idiopathic Arthritis
by: Auksė Arbačiauskaitė, et al.
Published: (2019-03-01)

Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review
by: Michelle M. A. Kip, et al.
Published: (2019-05-01)

Haptoglobin in Juvenile Idiopathic Arthritis
by: Lillemor Berntson, et al.
Published: (2022-12-01)

Juvenile Idiopathic Arthritis and Exercise
by: Pınar Kısacık, et al.
Published: (2016-04-01)

Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis
by: Claire E. H. Barber, et al.
Published: (2020-03-01)

JAK inhibitors in systemic juvenile idiopathic arthritis
by: Tingyan He, et al.
Published: (2023-04-01)

Glucose metabolism in systemic juvenile idiopathic arthritis
by: Papatsorn Suppasit, et al.
Published: (2022-07-01)

A novel method for eliciting foot care preferences in juvenile idiopathic arthritis: a discrete choice experiment
by: Woodburn Jim, et al.
Published: (2011-05-01)

An exploration of parents' preferences for foot care in juvenile idiopathic arthritis: a possible role for the discrete choice experiment
by: Gordon J Hendry, et al.
Published: (2014-01-01)

Early treatment with infliximab in patients with juvenile idiopathic arthritis
by: Mitenko EV, et al.
Published: (2011-09-01)

ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2009-01-01)

JUVENILE IDIOPATHIC ARTHRITIS: CLINICAL PICTURE, DIAGNOSIS, TREATMENT
by: E. I. Alexeeva
Published: (2015-02-01)

ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2009-07-01)

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
by: Sonja Falvey, et al.
Published: (2017-06-01)

Patient’s experiences with the care for juvenile idiopathic arthritis across Europe
by: E. H. Pieter. van Dijkhuizen, et al.
Published: (2018-02-01)

Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients
by: Marie-Therese Holzer, et al.
Published: (2022-04-01)

Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans
by: Yukiko Kimura, et al.
Published: (2017-04-01)